• Natalia Chevtaeva Russian Presidential Academy of National Economy and Public Administration, Yekaterinburg
  • Elena Kachanova Russian Presidential Academy of National Economy and Public Administration, Yekaterinburg
  • Natalia Makhova Russian Presidential Academy of National Economy and Public Administration, Yekaterinburg
Keywords: health policy, treatment, drugs, addiction


In recent decades, the illicit drug problem within Russia’s population has become more severe. The threat of drug addiction is not only socially unacceptable but, in general, is fast becoming a major public health problem in Russia. The study objective is to identify factors that determine the availability of support from the state anti-drug policy of Russia, as exemplified by the Khanty-Mansiysk Autonomous District, Yugra. Monitoring of the drug situation, carried out in Khanty-Mansiysk, Yugra in 2014 - 2016, provides the background data along with results of a sociological survey of 2000 residents, and input from an expert panel. Indicators of drug-related morbidity in Khanty-Mansiysk, Yugra, are compared with those for the Russian Federation as a whole. Parameters and criteria for providing access to health care for the population are established along with recommendations for the authorities on how to optimize drug treatment for the population. The monitoring not only provides data to identify the vulnerabilities but, with the accumulated positive experience from Russia, also assists those providing drug treatment to the population to focus efforts in alleviating this major social problem.


Agarwal, R., Daher, AM., Mohd Ismail, N. (2013). Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang Valley in Malaysia. Malays J Med Sci.20(2):52-61. PubMed PMID: 23983578; PubMed Central PMCID: PMCPMC3744000.

Barrientos-Gutierrez, T., Vidaña-Pérez, D., Zepeda-Tello, R., Hernández-Ávila, M. (2016). Regulating illegal drug markets: what legal markets can teach us. Lancet.;387(10037):2505. doi: 10.1016/S0140-6736(16)30796-6. PubMed PMID: 27353682.

Berry, MD., Accelus, TR. (2015). Business of Health: Business of Healthcare. Issue Brief Health Policy Track Serv.1-76. PubMed PMID: 27116766.

Chang, HY. Lyapustina T, Rutkow L, Daubresse M, Richey M, Faul M (2016). Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug Alcohol Depend.165:1-8. doi: 10.1016/j.drugalcdep.2016.04.033. PubMed PMID: 27264166.

Chung, YY, Shek, DT. (2008). Reasons for seeking treatment among young abusers in Hong Kong. Int J Adolesc Med Health.;20(4):441–448.

European Monitoring Centre for Drugs and Drug Addiction (2013). European drug report: trends and developments. Luxembourg: Office for Official Publications of the European Communities.

Gossop, M. (2013). Living with drugs. 7th ed. Farnham, Surrey; Burlington, VT: Ashgate;. 282.

Haerens, M., Zott, LM. (2013). Prescription drug abuse. Detroit: Greenhaven Press. 255.